Children and families bear a significant burden of human immunodeficiency virus disease globally, particularly in sub-Saharan Africa. Care of severely affected families can be adversely impacted by high medication burdens and overwhelmed caregivers, who themselves may be human immunodeficiency virus infected. Family-centered care involving joint clinic days, treatment preparation, adherence counseling, and community-based follow-up may improve the care of family units. We describe the successful treatment of a single family composed of 6 infected members living in a rural African setting.
Unaids.AIDS Epidemic Update: Joint United Nations Program on HIV/AIDS (UNAIDS) and World Health Organization, December 2007. Report No: UNAIDS/ 07.27E/JC1322E; 2007.
2.
Nilsson Schonnesson L., Williams ML, Ross MW, Bratt G., Keel B.Factors associated with suboptimal antiretroviral therapy adherence to dose, schedule, and dietary instructions. AIDS Behav. 2007;11:175-183.
3.
Bartlett JA, DeMasi R., Quinn J., Moxham C., Rousseau F.Overview of the effectiveness of triple combination therapy in antiretroviral-naive HIV-1 infected adults. AIDS (London, England). 2001;15:1369-1377.
4.
Diabate S., Alary M., Koffi CKDeterminants of adherence to highly active antiretroviral therapy among HIV-1-infected patients in Cote d'Ivoire. AIDS (London, England). 2007;21:1799-1803.
5.
Orrell C., Bangsberg DR, Badri M., Wood R.Adherence is not a barrier to successful antiretroviral therapy in South Africa . AIDS (London, England). 2003;17:1369-1375.
6.
Mills EJ, Nachega JB, Buchan I., et al. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA. 2006 ;296:679-690.
7.
Ahoua L., Guenther G., Pinoges L., et al. Children antiretroviral treatment outcomes after 12 or 24 months of HAART in the HIV care program of North-Western Uganda. In: 4th International AIDS Society Conference on HIV Pathogenesis , Treatment and Prevention. Sydney ; 2007.
8.
Watson DC, Farley JJEfficacy of and adherence to highly active antiretroviral therapy in children infected with human immunodeficiency virus type 1. Pediatr Infect Dis J. 1999;18:682-689.
9.
Martin S., Elliott-DeSorbo DK, Wolters PL, et al. Patient, caregiver and regimen characteristics associated with adherence to highly active antiretroviral therapy among HIV-infected children and adolescents. Pediatr Infect Dis J. 2007 ;26:61-67.
10.
Müller AD, Bode S., Myer L., Roux P., von Steinbuchel N.Electronic measurement of adherence to pediatric antiretroviral therapy in South Africa. Pediatr Infect Dis J. 2008;27:257-262.
11.
Interim WHO Clinical Staging of HIV/AIDS and HIV/ AIDS Case Definitions for Surveillance: African Region. Geneva: World Health Organization; February 2005.
12.
Centers for Disease Control and Prevention.1994 Revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MWMR Morb Mortal Wkly Rep1994;43:1-7.
13.
National AIDS and Sexually Transmitted Diseases Control Program.Antiretroviral Therapy Guidelines. 3rd ed. Nairobi: NASCOP ; 2006.
14.
Harries AD, Maher D., Nunn P.An approach to the problems of diagnosing and treating adult smear-negative pulmonary tuberculosis in high-HIV-prevalence settings in sub-Saharan Africa . Bull World Health Organ. 1998;76:651-662.
15.
Starke JRPediatric tuberculosis: time for a new approach. Tuberculosis (Edinburgh, Scotland). 2003;83: 208-212.
16.
Beyers N., Gie RP, Schaaf HS, et al. A prospective evaluation of children under the age of 5 years living in the same household as adults with recently diagnosed pulmonary tuberculosis . Int J Tuberc Lung Dis. 1997;1: 38-43.
17.
Lawn SD, Myer L., Orrell C., Bekker LG, Wood R.Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design. AIDS (London, England). 2005;19: 2141-2148.
18.
Nduati R., Richardson BA, John G., et al. Effect of breast-feeding on mortality among HIV-1 infected women: a randomised trial. Lancet. 2001;357:1651-1655.
